These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25173136)

  • 1. Primary brain tumors: introduction.
    Aiken RD; Byrne RW
    Semin Oncol; 2014 Aug; 41(4):437. PubMed ID: 25173136
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.
    Lou E; Turner S; Sumrall A; Reardon DA; Desjardins A; Peters KB; Sampson JH; Friedman HS; Vredenburgh JJ
    J Clin Oncol; 2011 Oct; 29(28):e739-42. PubMed ID: 21900098
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.
    Kilickap S; Oztoprak I; Yucel B
    Acta Oncol; 2012 Apr; 51(4):544-6. PubMed ID: 22201408
    [No Abstract]   [Full Text] [Related]  

  • 4. Localized skin necrosis by bevacizumab.
    Frances L; Guijarro J; del Carmen Leiva-Salinas M; Albares MP; Ramon R
    Eur J Dermatol; 2013 Apr; 23(2):251-2. PubMed ID: 23568603
    [No Abstract]   [Full Text] [Related]  

  • 5. Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide.
    Yeo KK; Puscasiu E; Keating RF; Rood BR
    J Neurosurg Pediatr; 2013 Jun; 11(6):682-6. PubMed ID: 23540527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab.
    Morana G; Piccardo A; Garrè ML; Nozza P; Consales A; Rossi A
    J Clin Oncol; 2013 Jan; 31(1):e1-5. PubMed ID: 23169514
    [No Abstract]   [Full Text] [Related]  

  • 7. Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.
    Bautista F; Paci A; Minard-Colin V; Dufour C; Grill J; Lacroix L; Varlet P; Valteau-Couanet D; Geoerger B
    Pediatr Blood Cancer; 2014 Jun; 61(6):1101-3. PubMed ID: 24375920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of brain metastases.
    Lukas RV; Gabikian P; Garza M; Chmura SJ
    Oncology; 2014; 87(6):321-9. PubMed ID: 25227433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A congenital brain tumor associated with assisted in vitro fertilization. Case report.
    Das A; Simmons C; Danielpour M
    J Neurosurg; 2005 Nov; 103(5 Suppl):451-3. PubMed ID: 16302619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience with targeted therapy in glioblastoma multiforme].
    Kiss E; Lahm E; Vachaja J; Nagy P; Bazsó P; Fekete Z; Takácsi-Nagy Z; Pápai Z
    Magy Onkol; 2013 Dec; 57(4):264-8. PubMed ID: 24353992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taming glioblastoma by targeting angiogenesis: 3 years later.
    Wong ET; Brem S
    J Clin Oncol; 2011 Jan; 29(2):124-6. PubMed ID: 21135277
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
    Kovic B; Xie F
    J Clin Oncol; 2015 Jul; 33(20):2296-302. PubMed ID: 26014296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of a recurrent glioblastoma treated with bevacizumab.
    Furuta T; Nakada M; Misaki K; Sato Y; Hayashi Y; Nakanuma Y; Hamada J
    Brain Tumor Pathol; 2014 Jan; 31(1):32-9. PubMed ID: 23504126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of surgical resection on adjuvant therapy and outcome.
    Benesch M; Urban C
    J Clin Oncol; 1998 Jan; 16(1):389-90. PubMed ID: 9440770
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature.
    Kamamoto D; Sasaki H; Ohara K; Mizutani K; Yoshida K
    Brain Tumor Pathol; 2016 Oct; 33(4):271-275. PubMed ID: 27472995
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection.
    Friedman GK; Spiller SE; Harrison DK; Fiveash JB; Reddy AT
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e123-6. PubMed ID: 23425999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for gliomas in children].
    Sawamura Y
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():478-82. PubMed ID: 16201567
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.
    Ku GY; Krol G; Ilson DH
    J Clin Oncol; 2007 May; 25(13):e14-6. PubMed ID: 17470852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
    Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
    Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
    Khasraw M; Bell D; Wheeler H
    J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.